UBX
Companies
NASDAQ
Unity Biotechnology Inc.
Health Care
$0.79
-$0.19 (-19.04%)
Price Chart
Overview
About UBX
unity biotechnology is developing therapeutics to extend healthspan by slowing, halting or reversing diseases of aging. unity's initial focus is on creating senolytic medicines to selectively eliminate senescent cells and thereby treat age-related diseases, such as osteoarthritis, eye diseases and pulmonary diseases. more information is available at www.unitybiotechnology.com.
Market Cap
$26.9M
Volume
163.5K
Avg. Volume
108.9K
P/E Ratio
-0.44534484
Dividend Yield
0.00%
Employees
32.0
Company Information
Risk & Correlation Analysis
Market Correlation
1.68
High Correlation
Volatility
High (1.00)
Relative to market
Macro Factor Sensitivities
Interest Rates
Low Sensitivity
Inflation
Low Sensitivity
GDP Growth
High Sensitivity
Liquidity
Low Sensitivity
Commodity Prices
Low Sensitivity
Credit Quality
Medium Sensitivity
Portfolio Impact
Forecasts & Predictions
1-Month Target
$XXX.XX
+X.X% Potential
3-Month Target
$XXX.XX
+X.X% Potential
12-Month Target
$XXX.XX
+X.X% Potential
Technical Analysis
Based on technical indicators and chart patterns, UBX shows...
AI Sentiment Analysis
Market sentiment analysis indicates...
Key Statistics
Market Cap$26.9M
Volume163.5K
P/E Ratio-0.45
Dividend Yield0.00%
Important Dates
Next Dividend
Next Earnings
April 23, 2025Related Securities
Pricing info last updated June 18, 2025 (after market close)Other info last updated April 2, 2025